SCS — Stem Cells Spin SA Income Statement
0.000.00%
Last trade - 00:00- PLN15.21m
- PLN15.32m
- PLN0.05m
- 36
- 10
- 77
- 32
Annual income statement for Stem Cells Spin SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.268 | 0.526 | 0.248 | 0.419 | 0.054 |
| Cost of Revenue | |||||
| Gross Profit | 0.261 | 0.502 | 0.228 | 0.375 | 0.047 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.227 | 0.605 | 0.217 | 0.57 | 0.571 |
| Operating Profit | 0.042 | -0.079 | 0.031 | -0.15 | -0.516 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.006 | -0.127 | 0.027 | -0.154 | -0.52 |
| Net Income After Taxes | 0.006 | -0.127 | 0.027 | -0.154 | -0.52 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.006 | -0.127 | 0.027 | -0.154 | -0.52 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.006 | -0.127 | 0.027 | -0.154 | -0.52 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0 | -0.003 | -0.005 | -0.004 | -0.013 |
| Dividends per Share |